首页> Journal of neuro-oncology.> Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

导出原文传递

翻译打印收藏纠错

第一作者： Gunjur, Ashray

作者： Gunjur, Ashray ^[1] ; Balasubramanian, Adithya ^[2] ; Hafeez, Umbreen ; Menon, Siddharth ; Cher, Lawrence ; Parakh, Sagun ; Gan, Hui Kong

作者单位： Austin Research Institute,Austin Hlth ^[1] Austin Research Institute,Austin Hosp ^[2]

关键词 Glioblastoma Drug development Preclinical models Phase 1 trials RANDOMIZED PHASE-II I/II TRIAL T-CELLS RECURRENT TEMOZOLOMIDE MODELS GLIOMA ORGANIZATION ENZASTAURIN CILENGITIDE

发布时间 2023-01-07

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Journal of neuro-oncology.

2022年159卷3期

539-549页

相似文献

中文期刊
外文期刊
学位论文
会议论文

浏览0

Journal of neuro-oncology.

2022年159卷3期

539-549页

检索历史清除

Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

Journal of neuro-oncology.

相似文献

同项目论文

Journal of neuro-oncology.

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Poor correlation between preclinical and patient efficacy data for tumor targeted monotherapies in glioblastoma: the results of a systematic review

Journal of neuro-oncology.

相似文献

同项目论文

Journal of neuro-oncology.

相关期刊

检索历史清除